Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous
system characterized by inflammatory demyelination and axonal/neuronal damage. The …

Multiple sclerosis is often diagnosed in patients who are planning on having children.
Although multiple sclerosis does not negatively influence most pregnancy outcomes, less is …

Background and Objectives Early treatment is associated with better long-term outcomes in
patients with a first demyelinating event and early multiple sclerosis (MS). However …

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
characterized by demyelination and axonal degeneration. MS patients typically present with …

Background: Cognitive impairment affects 50%–75% of people with secondary progressive
multiple sclerosis (PwSPMS). Improving our ability to predict cognitive decline may facilitate …

Introduction Neurological deterioration, soon after anti-copper treatment initiation, is
problematic in the management of Wilson's disease (WD) and yet reports in the literature are …

Multiple sclerosis (MS) is an autoimmune, neurodegenerative disease that is driven by
immune system-mediated demyelination of nerve axons. While diseases such as cancer …

Background High-efficacy disease-modifying therapies have been proven to slow disability
accrual in adults with relapsing–remitting multiple sclerosis. However, their impact on …

Objective To compare the clinical effectiveness of high-and low-efficacy treatments in
patients with recently active and inactive secondary progressive multiple sclerosis (SPMS) …

Abstract Die Multiple Sklerose ist eine komplexe, autoimmun vermittelte Erkrankung des
zentralen Nervensystems, charakterisiert durch inflammatorische Demyelinisierung sowie …